medigraphic.com
Instituto Nacional de Salud Pública

2025, Number 6

<< Back Next >>

salud publica mex 2025; 67 (6)

Prevalence of diabetes and glycemic control in Mexico, Ensanut 2021-2024

Reyes-García A, Basto-Abreu A, Reyes-Sánchez F, Stern D, Romero-Martínez M, Campos-Nonato I, Rojas-Martínez R, Aguilar-Salinas CA, Barrientos-Gutiérrez T

Language: Spanish
References: 33
Page: 622-632
PDF size: 691.77 Kb.


ABSTRACT

Objective. To estimate the prevalence of type 2 diabetes (T2D), medical care, pharmacological treatment, and glycemic control in Mexico at national, regional, and state levels. Materials and methods. Data from the Encuesta Nacional de Salud y Nutrición Continua 2021-2024 were used to estimate the prevalence of total-, diagnosed-, and undiagnosed-T2D, and prevalence of medical care, treatment, and glycemic control (HbA1c ‹7%), stratified by sociodemographic variables. Results. National T2D prevalence was 17.0%, with 11.6% previously diagnosed and 5.4% undiagnosed. Durango and Campeche had the highest diagnosed prevalence (~16%). Central and North-Pacific regions reported the highest total (21.1 and 20.7%) and undiagnosed (8.1 and 7.3%) T2D prevalences. Among diagnosed population, 73.0% received medical care, 90.9% were under treatment, and 33.0% achieved glycemic control, with the lowest proportions in Central-Pacific, Mexico City and Peninsula (‹30%). Conclusion. Findings reveal geographic disparities and underscore the need for policies focused on early detection, sustained care, and effective glycemic control of T2D in Mexico.


REFERENCES

  1. GBD 2021 Diabetes Collaborators. Global, regional, and nationalburden of diabetes from 1990 to 2021, with projections of prevalenceto 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203-34. https://doi.org/10.1016/S0140-6736(23)01301-6

  2. Villalpando S, de la Cruz V, Rojas R, Shamah-Levy T, Ávila MA, Gaona B, etal. Prevalence and distribution of type 2 diabetes mellitus in Mexican adultpopulation: a probabilistic survey. Salud Publica Mex. 2010;52(supl 1):s19-26. https://doi.org/10.1590/s0036-36342010000700005

  3. Basto-Abreu A, Reyes-García A, Stern D, Torres-Ibarra L, Rojas-MartínezR, Aguilar-Salinas CA, et al. Cascadas de tamizaje y atención de la diabetestipo 2 en México. Salud Publica Mex. 2024;66(4):530-8. https://doi.org/10.21149/16209

  4. Montoya A, Gallardo-Rincón H, Silva-Tinoco R, García-Cerde R, Razo C,Ong L, et al. Epidemia de diabetes tipo 2 en México. Análisis de la carga dela enfermedad 1990-2021 e implicaciones en la política pública. Gac MedMex. 2023;159:488-500. https://doi.org/10.24875/GMM.23000378

  5. Zhang X, Bullard KM, Gregg EW, Beckles GL, Williams DE, Barker LE, etal. Access to health care and control of ABCs of diabetes. Diabetes Care.2012;35(7):1566-71. https://doi.org/10.2337/dc12-0081

  6. Redondo A, Benach J, Subirana I, Martinez JM, Muñoz MA, Masiá R, et al.Trends in the prevalence, awareness, treatment, and control of cardiovascularrisk factors across educational level in the 1995-2005 period. Ann Epidemiol.2011;21(8):555-63. https://doi.org/10.1016/j.annepidem.2011.02.008

  7. Basto-Abreu AC, López-Olmedo N, Rojas-Martínez R, Aguilar-SalinasCA, De la Cruz-Góngora VV, Rivera-Dommarco J, et al. Prevalenceof diabetes and glycemic control in Mexico: national results from2018 and 2020. Salud Publica Mex. 2021;63(6):725-33. https://doi.org/10.21149/12842

  8. Hill-Briggs F, Adler NE, Berkowitz SA, Chin MH, Gary-Webb TL, Navas-Acien A, et al. Social determinants of health and diabetes: a scientific review.Diabetes Care. 2020;44: 258-79. https://doi.org/10.2337/dci20-0053

  9. Presley CA, Khodneva Y, Juarez LD, Howell CR, Agne AA, Riggs KR, etal. Trends and predictors of glycemic control among adults with type 2diabetes covered by Alabama Medicaid, 2011-2019. Prev Chronic Dis.2023;20:220332. https://doi.org/10.5888/pcd20.220332

  10. Azagew AW, Mekonnen CK, Lambie M, Shepherd T, Babatunde OO.Poor glycemic control and its predictors among people living withdiabetes in low- and middle-income countries: a systematic review andmeta-analysis. BMC Public Health. 2025;25:714. https://doi.org/10.1186/s12889-025-21828-y

  11. Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-Arrendondo S, Colchero MA, Gaona-Pineda EB, et al. Metodología de laEncuesta Nacional de Salud y Nutrición 2022 y Planeación y diseño de laEnsanut Continua 2020-2024. Salud Publica Mex. 2022;64(5):522-9. https://doi.org/10.21149/14186

  12. Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-SalinasCA, Moreno-Banda GL, Carnalla M, et al. Prevalencia de prediabetes y diabetesen México: Ensanut 2022. Salud Publica Mex. 2023;65(supl 1):s163-8.https://doi.org/10.21149/14832

  13. Romero-Martínez M, Shamah-Levy T, Barrientos-Gutiérrez T,Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, et al. EncuestaNacional de Salud y Nutrición 2023: metodología y avances de la EnsanutContinua 2020-2024. Salud Publica Mex. 2023;65(4):394-401. https://doi.org/10.21149/15081

  14. Romero-Martínez M, Barrientos-Gutiérrez T, Cuevas-Nasu L, Bautista-Arredondo S, Colchero MA, Gaona-Pineda EB, et al. Metodología dela Encuesta Nacional de Salud y Nutrición 2021. Salud Publica Mex.2021;63(6):813-8. https://doi.org/10.21149/13348

  15. Secretaría de Salud. Protocolo clínico para el diagnóstico y tratamientode la diabetes. México: SS, 2015 [citado junio 30, 2025]. Disponible en:https://www.gob.mx/salud/documentos/protocolo-clinico-para-el-diagnostico-y-tratamiento-de-la-diabetes

  16. American Diabetes Association Professional Practice Committee. 2.Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2025.Diabetes Care. 2025;48(supl 1):S27-49. https://doi.org/10.2337/dc25-S002

  17. American Diabetes Association Professional Practice Committee. GlycemicGoals and Hypoglycemia: Standards of Care in Diabetes-2025. DiabetesCare. 2025;48(supl 1): S128-145. https://doi.org/10.2337/dc25-S006

  18. Moreno-Altamirano L, García-García JJ, Soto-Estrada G, CapraroS, Limón-Cruz D. Epidemiología y determinantes sociales asociados ala obesidad y la diabetes tipo 2 en México. Rev Med Hosp Gen Mex.2014;77(3):114-23. https://doi.org/10.1016/j.hgmx.2014.07.002

  19. López-López E, Ortiz-Gress AA, López-Carbajal MJ. Intervención educativasobre el nivel de conocimientos en pacientes con diabetes y bajao nula escolaridad. Investigación en Educación Médica. 2016;5(17):11-16.https://doi.org/10.1016/j.riem.2015.08.003

  20. Reyes-García A, Basto-Abreu A, Reyes-Sánchez F, Stern D, Romero-Martínez M, Campos-Nonato I, et al. Material suplementario. Prevalenciade diabetes y control glucémico en México a nivel nacional yestatal: Ensanut 2021-2024. Figshare, 2025. https://doi.org/10.6084/m9.figshare.30461753

  21. Secretaría de Salud. Estrategia nacional para la prevención y el controldel sobrepeso, la obesidad y la diabetes. México: SS, 2013 [citado junio 30,2025]. Disponible en: https://www.gob.mx/salud/cenaprece/documentos/estrategia-nacional-para-la-prevencion-y-el-control-del-sobrepeso-laobesidad-y-la-diabetes-136837

  22. Secretaría de Salud. Cuestionario de Factores de Riesgo. México: Cenaprese,Gobierno de México. 2015 [citado junio 30, 2025]. Disponibleen: https://www.gob.mx/salud/documentos/cuestionario-de-factores-deriesgo

  23. Barquera S, Hernández-Alcaraz C, Jáuregui A, Medina C, Mendoza-Herrera K, Pedroza-Tobias A, et al. Diabetes awareness, treatment, andcontrol among Mexico City residents. Diabetology. 2021;2(1):16-30.https://doi.org/10.3390/diabetology2010002

  24. Bautista-Arredondo S. Utilización de servicios públicos de salud enMéxico: Uno de los retos críticos del sistema de salud. Méxco: INSP, 2025[citado junio 30, 2025]. Disponible en: https://www.insp.mx/informacionrelevante/utilizacion-de-servicios-publicos-de-salud-en-mexico-uno-delos-retos-criticos-del-sistema-de-salud

  25. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnoseddiabetes in adults. Diabetes Res Clin Pract. 2014;103(2):150-60.https://doi.org/10.1016/j.diabres.2013.11.001

  26. Ogurtsova K, Guariguata L, Barengo NC, Ruiz PL-D, Sacre JW, KarurangaS, et al. IDF diabetes Atlas: Global estimates of undiagnosed diabetesin adults for 2021. Diabetes Res Clin Pract. 2022;183:109118. https://doi.org/10.1016/j.diabres.2021.109118

  27. Gallardo-Rincón H, Ríos-Blancas MJ, Montoya A, Saucedo-MartínezR, Morales-Juárez L, Mujica R, et al. Evaluation of effective coverage fortype 2 diabetes in Mexican primary care health information systems: aretrospective registry analysis. Int J Equity Health. 2023;22:61. https://doi.org/10.1186/s12939-023-01878-7

  28. Knaul FM, González-Pier E, Gómez-Dantés O, García-Junco D,Arreola-Ornelas H, Barraza-Lloréns M, et al. The quest for universalhealth coverage: achieving social protection for all in Mexico. Lancet.2012;380(9849):1259-79. https://doi.org/10.1016/S0140-6736(12)61068-X

  29. Comisión Económica para América Latina y el Caribe. EstudioEconómico de América Latina y el Caribe, 2020 (LC/PUB.2020/12-P).Santiago: Cepal, 2020 [citado junio 30, 2025]. Disponible en: https://repositorio.cepal.org/server/api/core/bitstreams/245e6e2d-7409-4a75-a59e-468da76d48fe/content

  30. Consejo Nacional de Evaluación de la Política de Desarrollo Social.Estudio sobre el derecho a la salud 2023: un análisis cualitativo. Ciudadde México: Coneval, 2023 [citado junio 30, 2025]. Disponible en: https://www.coneval.org.mx/EvaluacionDS/PP/CEIPP/IEPSM/Documents/E_Derecho_Salud_2023.pdf

  31. Colchero MA, Gómez R, Figueroa JL, Rodríguez-Atristain A, Bautista-Arredondo S. Aumento en la oferta de consultorios adyacentes a farmaciasy atención en servicios públicos en México entre 2012 y 2018. SaludPublica Mex. 2020;62(6):851-8. https://doi.org/10.21149/11547

  32. Goh LH, Siah CJR, Tam WWS, Tai ES, Young DYL. Effectiveness of thechronic care model for adults with type 2 diabetes in primary care: asystematic review and meta-analysis. Syst Rev. 2022;11(1):273.https://doi.org/10.1186/s13643-022-02117-w

  33. U.S. Centers for Disease Control and Prevention (CDC). NationalDiabetes Statistics Report. Atlanta: CDC, 2024 [citado abril 11, 2025].Disponible en: https://www.cdc.gov/diabetes/php/data-research/index.html




2020     |     www.medigraphic.com